Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Sell
37
HLNCF Quote, Financials, Valuation and Earnings
Last price:
$5.0700
Seasonality move
:
0.16%
Day range:
$4.9720 - $5.2000
52-week range:
$3.9000 - $5.4700
Dividend yield:
1.71%
P/E ratio:
25.18x
P/S ratio:
3.24x
P/B ratio:
2.26x
Volume:
6.6K
Avg. volume:
33.6K
1-year change:
21.9%
Market cap:
$45.8B
Revenue:
$14.4B
EPS (TTM):
$0.20
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Haleon PLC has -- downside to fair value with a price target of -- per share.
HLNCF vs. S&P 500
-
Over the past 5 trading days, Haleon PLC has underperformed the S&P 500 by -1.73% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Haleon PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Haleon PLC has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Haleon PLC reported revenues of $3.5B.
Earnings Growth
-
Haleon PLC has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Haleon PLC reported earnings per share of $0.03.
Enterprise value:
55.6B
EV / Invested capital:
--
Price / LTM sales:
3.24x
EV / EBIT:
18.87x
EV / Revenue:
3.87x
PEG ratio (5yr expected):
0.59x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
18.87x
Gross Profit (TTM):
$8.7B
Return On Assets:
4.3%
Net Income Margin (TTM):
12.86%
Return On Equity:
8.91%
Return On Invested Capital:
5.64%
Operating Margin:
12.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $14.6B | $14.1B | $14.4B | $3.4B | $3.5B | |
| Gross Profit | $8.9B | $8.4B | $8.7B | $1.8B | $2B | |
| Operating Income | $2.5B | $2.5B | $2.8B | $336.6M | $448.1M | |
| EBITDA | $2.7B | $2.6B | $2.9B | $393.7M | $510.8M | |
| Diluted EPS | $0.14 | $0.14 | $0.20 | -- | $0.03 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $7.1B | $4.9B | $6.1B | $7.2B | |
| Total Assets | -- | $46.5B | $42.1B | $43.4B | $43.1B | |
| Current Liabilities | -- | $5.7B | $5.3B | $5.9B | $7.3B | |
| Total Liabilities | -- | $10.8B | $22.2B | $22.1B | $22.7B | |
| Total Equity | -- | $35.7B | $19.9B | $21.3B | $20.4B | |
| Total Debt | -- | $1.2B | $12.4B | $11.8B | $12.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.4B | -- | -- | $937.5M | $1.1B | |
| Cash From Investing | -- | -- | -- | -$235.3M | $296.5M | |
| Cash From Financing | -- | -- | -- | -$848.6M | -$2B | |
| Free Cash Flow | -- | -- | -- | $757.3M | $921M | |
HLNCF
Sector
Market Cap
$45.8B
$260.2M
Price % of 52-Week High
92.6%
73.59%
Dividend Yield
1.71%
0%
Shareholder Yield
--
3.16%
1-Year Price Total Return
21.9%
-9.69%
Beta (5-Year)
--
0.419
Dividend yield:
1.71%
Annualized payout:
$0.08
Payout ratio:
26.52%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$5.0550
200-day SMA
Buy
Level
$4.8246
Bollinger Bands (100)
Buy
Level
4.6173 - 5.0773
Chaikin Money Flow
Sell
Level
-719K
20-day SMA
Buy
Level
$4.9500
Relative Strength Index (RSI14)
Buy
Level
52.3501
ADX Line
Sell
Level
13.0709
Williams %R
Neutral
Level
-32.7381
50-day SMA
Buy
Level
$5.0149
MACD (12, 26)
Buy
Level
0.0242
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Neutral
Level
1.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7871)
Buy
CA Score
(Annual)
Level (-0.1227)
Buy
Beneish M-Score
(Annual)
Level (-2.5081)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.1064)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Stock Forecast FAQ
In the current month, HLNCF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HLNCF average analyst price target in the past 3 months is --.
-
Where Will Haleon PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Haleon PLC share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Haleon PLC?
Analysts are divided on their view about Haleon PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Haleon PLC is a Sell and believe this share price will rise from its current level to --.
-
What Is Haleon PLC's Price Target?
The price target for Haleon PLC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HLNCF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Haleon PLC is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HLNCF?
You can purchase shares of Haleon PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Haleon PLC shares.
-
What Is The Haleon PLC Share Price Today?
Haleon PLC was last trading at $5.0700 per share. This represents the most recent stock quote for Haleon PLC. Yesterday, Haleon PLC closed at $5.0650 per share.
-
How To Buy Haleon PLC Stock Online?
In order to purchase Haleon PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Is it Too Late to Buy Gold?
Amid deep uncertainties about the future of the US economy,…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is up 23.1% over the past day.
Sell
35
RGC alert for Apr 30
Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 14.88% over the past day.
